UPDATE 3-Abbott to buy Latin American drugmaker CFR in $2.9 bln deal
Reuters May 16 (Reuters) – Abbott Laboratories said on Friday it would acquire Chile's CFR Pharmaceuticals SA in a $2.9 billion deal that will more than double its branded generic drugs business in the fast-growing Latin American market. This is the first deal … |